Use of a masked or coated copper salt for the treatment of macular degeneration

Details for Australian Patent Application No. 2008231847 (hide)

Owner Novartis AG

Inventors Vandermander, Jacques; Kis, Georg Ludwig

Agent Davies Collison Cave

Pub. Number AU-A-2008231847

PCT Pub. Number WO2008/116806

Priority 07111322.9 28.06.07 EP; 07104792.2 23.03.07 EP

Filing date 19 March 2008

Wipo publication date 2 October 2008

International Classifications

A61K 33/34 (2006.01) Medicinal preparations containing inorganic active ingredients - Copper

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/116806 Priority application(s): WO2008/116806

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008231854-Combination medicaments for treating bacterial infections

2008231831-Method for producing surface-modified nanoparticulate metal oxides, metal hydroxides, and/or metal oxide hydroxides